Page 4 - Nasdaq Crsp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq crsp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Crsp Today - Breaking & Trending Today

CRISPR Therapeutics (NASDAQ:CRSP) Shares Gap Up Following Strong Earnings

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price gapped up prior to trading on Wednesday following a better than expected earnings announcement. The stock had previously closed at $78.73, but opened at $82.49. CRISPR Therapeutics shares last traded at $78.25, with a volume of 725,141 shares changing hands. The company reported $1.10 earnings […] ....

Nova Scotia , Jamesr Kasinger , Samarth Kulkarni , Wells Fargo Company , Royal Bank , T Rowe Price Investment Management Inc , Capital International Investors , Investment Management , Wolfe Research , Pricet Rowe Associates Inc , Blackrock Inc , Get Free Report , General Counsel James , International Investors , Rowe Price Investment Management , Crispr Therapeutics , Nasdaq Crsp ,

Wells Fargo & Company Increases CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $70.00

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target increased by stock analysts at Wells Fargo & Company from $55.00 to $70.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective suggests a potential […] ....

Nova Scotia , Samarth Kulkarni , Jamesr Kasinger , Royal Bank , York Mellon Corp , Blackrock Inc , Cibc World Market Inc , Wells Fargo Company , Us Bancorp , Fairfield Bush , Get Free Report , Wells Fargo , General Counsel James , New York Mellon Corp , Cibc World Market , World Market , Crispr Therapeutics , Nasdaq Crsp , Boost Price Target , Wells Fargo Amp Company ,

CRISPR Therapeutics (NASDAQ:CRSP) Given New $66.00 Price Target at Royal Bank of Canada

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its target price boosted by equities research analysts at Royal Bank of Canada from $57.00 to $66.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would indicate […] ....

Samarth Kulkarni , Jamesr Kasinger , Wolfe Research , Needham Company , Tradewinds Capital Management , Morgan Stanley , Therapeutics Company Profile , Headlands Technologies , Geneos Wealth Management Inc , Royal Bank , Blue Trust Inc , Get Free Report , General Counsel James , Wealth Management , Capital Management , Crispr Therapeutics , Nasdaq Crsp , Boost Price Target , Royal Bank Of Canada ,

Samarth Kulkarni Sells 6,370 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) Stock

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) CEO Samarth Kulkarni sold 6,370 shares of CRISPR Therapeutics stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $79.67, for a total value of $507,497.90. Following the sale, the chief executive officer now owns 194,257 shares in […] ....

Samarth Kulkarni , Needham Company , Blue Trust Inc , Headlands Technologies , Therapeutics Company Profile , Geneos Wealth Management Inc , Royal Bank , Tradewinds Capital Management , Get Free Report , Wealth Management , Capital Management , Crispr Therapeutics , Nasdaq Crsp , Insider Trading , Nsider Trades ,

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $66.00 at Royal Bank of Canada

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price objective raised by analysts at Royal Bank of Canada from $57.00 to $66.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price indicates a potential downside […] ....

Nova Scotia , Jamesr Kasinger , Samarth Kulkarni , Cibc World Market Inc , Blackrock Inc , Fairfield Bush , Needham Company , Morgan Stanley , York Mellon Corp , Royal Bank , Us Bancorp , Get Free Report , General Counsel James , New York Mellon Corp , Cibc World Market , World Market , Crispr Therapeutics , Nasdaq Crsp , Boost Price Target , Royal Bank Of Canada ,